Eurazeo (RF)
Euronext Paris · France · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 48.40 |
|---|---|
| 52-week range | 37.54 – 60.60 |
| Return, 1 month / 3 months | +4.0% / +4.2% |
| Return, 1 year / 3 years | −14.2% / +6.3% |
| Trend | Uptrend |
| RSI (14) | 66 |
| Volatility (1 year) | 28.9% |
| Worst drawdown (1 year) | -36.1% |
| Average daily value traded | 3.58M EUR |
| Dividend yield | 6.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Eurazeo is a French investment firm based in Paris that manages money for institutional and individual clients. It invests across private equity, venture capital, private debt and real assets, backing companies at different stages of development. Its funds and its own balance sheet are used to take stakes in businesses, and it also provides asset management services to outside investors. The firm works with entrepreneurs and management teams in Europe and beyond.
On this site Eurazeo appears as a stock on the Euronext Paris (France), code RF, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Eurazeo (RF) trades on the Euronext Paris in France. It last closed at EUR 48.40 on 27 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 82 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.2% and over the last three months it rose 4.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.5% | ||
| From 52-week high | -19.7% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.2% | ||
| 6-month return | 11.3% | ||
| 12-month return, skipping the last month | -17.6% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.1% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 3.58M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +6.6% |
|---|---|
| 1 month | +4.0% |
| 3 months | +4.2% |
| 6 months | +11.3% |
| 1 year | −14.2% |
| 3 years | +6.3% |
| 5 years | −28.2% |
Signals
| 50-day / 200-day average | 47.40 / 45.03 |
|---|---|
| Golden / death cross (60 days) | Golden, 45 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | EUR 2.9200 |
| 26 May 2025 | EUR 2.6500 |
| 14 May 2024 | EUR 2.4200 |
| 28 Apr 2023 | EUR 2.2000 |
| 2 May 2022 | EUR 1.2500 |
| 30 Apr 2021 | EUR 1.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.